American Cancer Society

American Cancer Society

The American Cancer Society was founded in 1913. Shane Jacobson serves as Chief Executive Officer effective August 2025, succeeding Wayne A. I. Frederick who held the interim role from 2024 to 2025. The organization directs resources toward research grants, patient services, and policy advocacy through its core mission. Capital deployment occurs through direct programs and two dedicated vehicles: the ACS Impact Venture Fund based in Kennesaw, Georgia, and the Cancer Crypto Fund. These structures support early-stage companies in oncology and related fields. Geographic reach centers on the United States with additional facilities in Puerto Rico. Confirmed assets include multiple Hope Lodge locations operated in partnership with sponsors such as AstraZeneca and the Richard M. Schulze Family Foundation. The organization lists no disclosed AUM figure. It maintains the American Cancer Society Cancer Action Network as a separate advocacy arm. Shane Jacobson assumed the CEO role in August 2025. Additional affiliations include the ACS National Consortium for Cancer Screening and Care and the CEOs Against Cancer network. The governance model separates philanthropic operations from investment vehicles through BrightEdge LLC, led by Managing Director Alice Pomponio. This setup allows targeted venture commitments while preserving the primary focus on mission-driven grantmaking and patient facilities.